← All indications
Demyelinating Diseases
Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.
Subtype terms (8)
More specific conditions that are subtypes of Demyelinating Diseases in the MeSH hierarchy.
- Demyelinating Autoimmune Diseases, CNS
10 drugs (8 approved, 2 experimental)
- Hereditary Central Nervous System Demyelinating Diseases
- Leukoencephalopathy, Progressive Multifocal
21 drugs (16 approved, 5 experimental)
- Marchiafava-Bignami Disease
- Myelinolysis, Central Pontine
- Ophthalmoplegic Migraine
- Polyradiculoneuropathy
25 drugs (17 approved, 8 experimental)
- Subacute Combined Degeneration
Drugs by status
Phase 4 trials (3)
Phase 3 trials (2)
Phase 2 trials (6)
Other trials (3)
Organizations
Organization Involved with Phase 4 Indications (5)
Organization Involved with Phase 2 Indications (4)
Organization Involved with Phase 1 Indications (3)
Organization Involved with Other Experimental Indications (1)